ALX Oncology Holdings Inc (ALXO)
1.29
-0.04
(-3.01%)
USD |
NASDAQ |
Nov 15, 16:00
1.29
0.00 (0.00%)
After-Hours: 20:00
ALX Oncology Holdings Gross Profit (Annual)
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2020 | 0.107M |
| December 31, 2019 | 0.436M |
| Date | Value |
|---|---|
| December 31, 2018 | 0.187M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
0.107M
Minimum
2020
0.436M
Maximum
2019
0.2715M
Average
0.2715M
Median
Gross Profit (Annual) Benchmarks
| Biomarin Pharmaceutical Inc | 1.904B |
| Neurocrine Biosciences Inc | 1.847B |
| Eton Pharmaceuticals Inc | 21.06M |
| Verve Therapeutics Inc | -- |
| Immuneering Corp | 0.00 |